European Commission approves agreement to secure 80 million doses of Moderna’s Covid-19 vaccine (mRNA-1273)

Delivery of the vaccine could begin as early as the first quarter of 2021 if approved by the European Medicines Agency. A rolling review of mRNBA-1273 was initiated by the CHMP on 17th November.

Source:

Biospace Inc.